Audentes Financial Statements From 2010 to 2024

Audentes Therapeutics financial statements provide useful quarterly and yearly information to potential Audentes Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Audentes Therapeutics financial statements helps investors assess Audentes Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Audentes Therapeutics' valuation are summarized below:
Audentes Therapeutics does not presently have any fundamental signals for analysis.
Check Audentes Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Audentes main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Audentes financial statements analysis is a perfect complement when working with Audentes Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Audentes Therapeutics Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Audentes Total Debt Analysis

Audentes Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Audentes Therapeutics Total Debt

    
  29.89 M  
Most of Audentes Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Audentes Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Based on the latest financial disclosure, Audentes Therapeutics has a Total Debt of 29.89 M. This is 98.91% lower than that of the Healthcare sector and 90.8% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.44% higher than that of the company.

Audentes Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Audentes Therapeutics's current stock value. Our valuation model uses many indicators to compare Audentes Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Audentes Therapeutics competition to find correlations between indicators driving Audentes Therapeutics's intrinsic value. More Info.
Audentes Therapeutics is number one stock in shares owned by institutions category among related companies. It is number one stock in current ratio category among related companies fabricating about  0.14  of Current Ratio per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Current Ratio for Audentes Therapeutics is roughly  7.24 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Audentes Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Audentes Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Audentes Therapeutics' earnings, one of the primary drivers of an investment's value.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Audentes Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Audentes Therapeutics' short interest history, or implied volatility extrapolated from Audentes Therapeutics options trading.

Pair Trading with Audentes Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Audentes Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Audentes Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Analog Devices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Analog Devices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Analog Devices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Analog Devices to buy it.
The correlation of Analog Devices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Analog Devices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Analog Devices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Analog Devices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in Audentes Stock

If you are still planning to invest in Audentes Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Audentes Therapeutics' history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators